NASDAQ:INMB | Cash Flow Statement | Inmune Bio, Inc.

Complete source-backed cash-flow history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.27M
2026-03-31-$5.41M-$3.4M
2025-12-31-$5.26M-$2.94M$143,000.00-$143,000.00$67,000.00
2025-09-30-$6.47M
2025-06-30-$24.46M
2025-03-31-$9.74M-$6.82M$5.27M
2024-12-31-$9.22M-$11.01M-$2.08M
2024-09-30-$12.09M
2024-06-30-$9.75M
2024-03-31-$11.03M-$7.48M-$2.5M
2023-12-31-$8.41M-$3.4M-$2.5M
2023-09-30-$8.56M
2023-06-30-$6.5M
2023-03-31-$6.54M-$1.14M
2022-12-31-$5.83M-$5.7M$0.00
2022-09-30-$7.73M
2022-06-30-$6.84M
2022-03-31-$6.9M-$8.87M$729,000.00
2021-12-31-$9.67M-$9.78M$0.00$0.00
2021-09-30-$9.46M
2021-06-30-$6.66M
2021-03-31-$4.56M-$5.09M$28.46M
2020-12-31-$3.2M-$2.39M$0.00
2020-09-30-$4.72M
2020-06-30-$2.11M
2020-03-31-$2.07M-$1.04M-$9,000.00
2019-12-31-$2.32M-$433,370.00$0.00
2019-09-30-$3.07M
2019-06-30-$392,083.00
2019-03-31-$1.9M-$1.39M$7.25M
2018-12-31-$1.88M-$462,377.00$0.00
2018-09-30-$1.54M
2018-06-30-$6.17M
2018-03-31-$2.85M-$328,841.00$900,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$45.93M-$22.58M$1.04M-$1.04M$27.61M
2024-12-31-$42.08M-$33.36M$18.21M
2023-12-31-$30.01M-$11.98M-$4.23M
2022-12-31-$27.3M-$22.69M$729,000.00
2021-12-31-$30.34M-$28.5M-$15M$96.36M
2020-12-31-$12.1M-$8.94M$23.9M
2019-12-31-$7.68M-$5.38M$12.21M
2018-12-31-$12.44M-$2.06M$900,000.00
2017-12-31-$831,486.00-$761,834.00-$100,000.00$2.06M